DLK1 and hepatocellular carcinoma: Therefore, we stratified publicly available HCC patient datasets according to PRAME expression and identified transcripts upregulated in PRAME-high patients including CTNND2, DLK1, KRT19, EPCAM, DKK1, AFP, MMP7 (Figure 2A).